GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...

Innoviva’s royalty portfolio includes respiratory assets partnered with Glaxo Group Limited (“GSK”). Innoviva is entitled to receive royalties from GSK on sales of RELVAR ® /BREO ® ELLIPTA ® and ANORO ...

Think AstraZeneca (AZN.L), GSK (GSK.L), Rolls-Royce (RR.L) and Lloyds (LLOY.L). Even the London Stock Exchange Group (LSEG.L) uses it! Covering human resources, financials and planning, Workday helps ...

GSK plc, Biocare Medical LLC, Teva Pharmaceuticals Industries, Mitsubishi chemical group corporation, Bristol-Myers Squibb Company in the Anxiety Disorder Treatment market. In 2023, the Anxiety ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

BOSTON, Nov. 12, 2024 /PRNewswire-PRWeb/ -- Syner-G BioPharma Group, a leading provider of regulatory strategy ... of myelofibrosis in adults who have moderate to severe anemia GSK announced today ...

“I definitely didn’t foresee that there’ll be so many fires to put out,” says the head of HR at BASF. “There’s a lot of ...

at 13:00 Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia GSK announced today that Health ... at 13:00 Syner-G BioPharma Group ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Under his leadership, the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK, Hero ...